trending Market Intelligence /marketintelligence/en/news-insights/trending/NQFMHQBgPFkhUWebQ4M0Sw2 content esgSubNav
In This List

IBio regains compliance with NYSE American's listing standards

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


IBio regains compliance with NYSE American's listing standards

NYSE American LLC informed iBio Inc. that the company had regained compliance with all of the stock exchange's listing standards.

The New York-based biotechnology company received a noncompliance notice in June after its stockholders' equity fell below the exchange's minimum requirement of $6 million and it booked net losses in five of its most recent fiscal years.

In August, NYSE American accepted iBio's plan to regain compliance with the stock exchange, which had a deadline of Dec. 6, 2019.

IBio provides product development and manufacturing services to clients, collaborators, and third-party customers.